nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—CYP3A7—Irinotecan—stomach cancer	0.064	0.138	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.064	0.138	CbGbCtD
Aprepitant—CYP2C9—Capecitabine—stomach cancer	0.0521	0.112	CbGbCtD
Aprepitant—CYP3A5—Irinotecan—stomach cancer	0.048	0.103	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.0469	0.101	CbGbCtD
Aprepitant—CYP3A7—Docetaxel—stomach cancer	0.0469	0.101	CbGbCtD
Aprepitant—CYP3A5—Docetaxel—stomach cancer	0.0352	0.0757	CbGbCtD
Aprepitant—CYP1A2—Fluorouracil—stomach cancer	0.0343	0.0738	CbGbCtD
Aprepitant—CYP2C9—Fluorouracil—stomach cancer	0.0309	0.0665	CbGbCtD
Aprepitant—TACR1—vagus nerve—stomach cancer	0.0255	0.345	CbGeAlD
Aprepitant—CYP3A4—Irinotecan—stomach cancer	0.0187	0.0403	CbGbCtD
Aprepitant—CYP3A4—Docetaxel—stomach cancer	0.0137	0.0295	CbGbCtD
Aprepitant—CYP3A4—Doxorubicin—stomach cancer	0.0102	0.022	CbGbCtD
Aprepitant—TACR3—smooth muscle tissue—stomach cancer	0.00948	0.128	CbGeAlD
Aprepitant—TACR1—hematopoietic system—stomach cancer	0.00417	0.0564	CbGeAlD
Aprepitant—TACR1—smooth muscle tissue—stomach cancer	0.00367	0.0497	CbGeAlD
Aprepitant—TACR1—digestive system—stomach cancer	0.0029	0.0392	CbGeAlD
Aprepitant—TACR1—endocrine gland—stomach cancer	0.0024	0.0324	CbGeAlD
Aprepitant—CYP3A7—endocrine gland—stomach cancer	0.00205	0.0277	CbGeAlD
Aprepitant—CYP3A7—liver—stomach cancer	0.00185	0.025	CbGeAlD
Aprepitant—TACR1—lymph node—stomach cancer	0.00166	0.0224	CbGeAlD
Aprepitant—CYP2C19—hematopoietic system—stomach cancer	0.00159	0.0215	CbGeAlD
Aprepitant—CYP3A7-CYP3A51P—liver—stomach cancer	0.00157	0.0212	CbGeAlD
Aprepitant—CYP1A2—hematopoietic system—stomach cancer	0.0013	0.0176	CbGeAlD
Aprepitant—CYP3A5—hematopoietic system—stomach cancer	0.00125	0.017	CbGeAlD
Aprepitant—CYP2C9—hematopoietic system—stomach cancer	0.00123	0.0167	CbGeAlD
Aprepitant—CYP2C19—digestive system—stomach cancer	0.00111	0.015	CbGeAlD
Aprepitant—CYP3A5—pancreas—stomach cancer	0.00102	0.0138	CbGeAlD
Aprepitant—CYP3A4—hematopoietic system—stomach cancer	0.000941	0.0127	CbGeAlD
Aprepitant—CYP2C19—endocrine gland—stomach cancer	0.000915	0.0124	CbGeAlD
Aprepitant—CYP1A2—digestive system—stomach cancer	0.000904	0.0122	CbGeAlD
Aprepitant—CYP3A5—digestive system—stomach cancer	0.000872	0.0118	CbGeAlD
Aprepitant—CYP2C9—digestive system—stomach cancer	0.000858	0.0116	CbGeAlD
Aprepitant—CYP2C19—liver—stomach cancer	0.000825	0.0112	CbGeAlD
Aprepitant—CYP1A2—endocrine gland—stomach cancer	0.000747	0.0101	CbGeAlD
Aprepitant—CYP3A5—endocrine gland—stomach cancer	0.000721	0.00975	CbGeAlD
Aprepitant—CYP2C9—endocrine gland—stomach cancer	0.000709	0.0096	CbGeAlD
Aprepitant—CYP1A2—liver—stomach cancer	0.000674	0.00911	CbGeAlD
Aprepitant—CYP3A4—digestive system—stomach cancer	0.000655	0.00886	CbGeAlD
Aprepitant—CYP3A5—liver—stomach cancer	0.00065	0.00879	CbGeAlD
Aprepitant—CYP2C9—liver—stomach cancer	0.00064	0.00865	CbGeAlD
Aprepitant—CYP3A4—endocrine gland—stomach cancer	0.000541	0.00732	CbGeAlD
Aprepitant—CYP3A4—liver—stomach cancer	0.000488	0.0066	CbGeAlD
Aprepitant—Alopecia—Methotrexate—stomach cancer	0.000155	0.000461	CcSEcCtD
Aprepitant—Bradycardia—Doxorubicin—stomach cancer	0.000155	0.00046	CcSEcCtD
Aprepitant—Dyspnoea—Docetaxel—stomach cancer	0.000154	0.000458	CcSEcCtD
Aprepitant—Somnolence—Docetaxel—stomach cancer	0.000154	0.000457	CcSEcCtD
Aprepitant—Mental disorder—Methotrexate—stomach cancer	0.000154	0.000457	CcSEcCtD
Aprepitant—Eye disorder—Epirubicin—stomach cancer	0.000154	0.000456	CcSEcCtD
Aprepitant—Tinnitus—Epirubicin—stomach cancer	0.000153	0.000455	CcSEcCtD
Aprepitant—Erythema—Methotrexate—stomach cancer	0.000153	0.000454	CcSEcCtD
Aprepitant—Malnutrition—Methotrexate—stomach cancer	0.000153	0.000454	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000153	0.000453	CcSEcCtD
Aprepitant—Cardiac disorder—Epirubicin—stomach cancer	0.000152	0.000453	CcSEcCtD
Aprepitant—Flushing—Epirubicin—stomach cancer	0.000152	0.000453	CcSEcCtD
Aprepitant—Vomiting—Fluorouracil—stomach cancer	0.000152	0.000453	CcSEcCtD
Aprepitant—Dyspepsia—Docetaxel—stomach cancer	0.000152	0.000453	CcSEcCtD
Aprepitant—Insomnia—Capecitabine—stomach cancer	0.000152	0.00045	CcSEcCtD
Aprepitant—Hypoaesthesia—Doxorubicin—stomach cancer	0.000151	0.000449	CcSEcCtD
Aprepitant—Rash—Fluorouracil—stomach cancer	0.000151	0.000449	CcSEcCtD
Aprepitant—Dermatitis—Fluorouracil—stomach cancer	0.000151	0.000449	CcSEcCtD
Aprepitant—Pharyngitis—Doxorubicin—stomach cancer	0.000151	0.000448	CcSEcCtD
Aprepitant—Paraesthesia—Capecitabine—stomach cancer	0.00015	0.000447	CcSEcCtD
Aprepitant—Decreased appetite—Docetaxel—stomach cancer	0.00015	0.000447	CcSEcCtD
Aprepitant—Headache—Fluorouracil—stomach cancer	0.00015	0.000446	CcSEcCtD
Aprepitant—Urinary tract disorder—Doxorubicin—stomach cancer	0.00015	0.000446	CcSEcCtD
Aprepitant—Dysgeusia—Methotrexate—stomach cancer	0.00015	0.000445	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000149	0.000444	CcSEcCtD
Aprepitant—Connective tissue disorder—Doxorubicin—stomach cancer	0.000149	0.000444	CcSEcCtD
Aprepitant—Dyspnoea—Capecitabine—stomach cancer	0.000149	0.000444	CcSEcCtD
Aprepitant—Fatigue—Docetaxel—stomach cancer	0.000149	0.000443	CcSEcCtD
Aprepitant—Angiopathy—Epirubicin—stomach cancer	0.000149	0.000443	CcSEcCtD
Aprepitant—Urethral disorder—Doxorubicin—stomach cancer	0.000149	0.000443	CcSEcCtD
Aprepitant—Nausea—Irinotecan—stomach cancer	0.000149	0.000442	CcSEcCtD
Aprepitant—Immune system disorder—Epirubicin—stomach cancer	0.000148	0.000441	CcSEcCtD
Aprepitant—Mediastinal disorder—Epirubicin—stomach cancer	0.000148	0.00044	CcSEcCtD
Aprepitant—Pain—Docetaxel—stomach cancer	0.000148	0.00044	CcSEcCtD
Aprepitant—Constipation—Docetaxel—stomach cancer	0.000148	0.00044	CcSEcCtD
Aprepitant—Back pain—Methotrexate—stomach cancer	0.000148	0.000439	CcSEcCtD
Aprepitant—Dyspepsia—Capecitabine—stomach cancer	0.000147	0.000438	CcSEcCtD
Aprepitant—Chills—Epirubicin—stomach cancer	0.000147	0.000438	CcSEcCtD
Aprepitant—Decreased appetite—Capecitabine—stomach cancer	0.000146	0.000433	CcSEcCtD
Aprepitant—Alopecia—Epirubicin—stomach cancer	0.000145	0.000431	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000145	0.00043	CcSEcCtD
Aprepitant—Fatigue—Capecitabine—stomach cancer	0.000144	0.000429	CcSEcCtD
Aprepitant—Mental disorder—Epirubicin—stomach cancer	0.000144	0.000428	CcSEcCtD
Aprepitant—Erythema multiforme—Doxorubicin—stomach cancer	0.000144	0.000427	CcSEcCtD
Aprepitant—Pain—Capecitabine—stomach cancer	0.000143	0.000426	CcSEcCtD
Aprepitant—Constipation—Capecitabine—stomach cancer	0.000143	0.000426	CcSEcCtD
Aprepitant—Erythema—Epirubicin—stomach cancer	0.000143	0.000425	CcSEcCtD
Aprepitant—Malnutrition—Epirubicin—stomach cancer	0.000143	0.000425	CcSEcCtD
Aprepitant—Feeling abnormal—Docetaxel—stomach cancer	0.000143	0.000424	CcSEcCtD
Aprepitant—Nausea—Fluorouracil—stomach cancer	0.000142	0.000423	CcSEcCtD
Aprepitant—Eye disorder—Doxorubicin—stomach cancer	0.000142	0.000422	CcSEcCtD
Aprepitant—Ill-defined disorder—Methotrexate—stomach cancer	0.000142	0.000421	CcSEcCtD
Aprepitant—Tinnitus—Doxorubicin—stomach cancer	0.000142	0.000421	CcSEcCtD
Aprepitant—Gastrointestinal pain—Docetaxel—stomach cancer	0.000142	0.00042	CcSEcCtD
Aprepitant—Anaemia—Methotrexate—stomach cancer	0.000141	0.00042	CcSEcCtD
Aprepitant—Flushing—Doxorubicin—stomach cancer	0.000141	0.000419	CcSEcCtD
Aprepitant—Cardiac disorder—Doxorubicin—stomach cancer	0.000141	0.000419	CcSEcCtD
Aprepitant—Flatulence—Epirubicin—stomach cancer	0.000141	0.000419	CcSEcCtD
Aprepitant—Dysgeusia—Epirubicin—stomach cancer	0.00014	0.000416	CcSEcCtD
Aprepitant—Back pain—Epirubicin—stomach cancer	0.000138	0.000411	CcSEcCtD
Aprepitant—Feeling abnormal—Capecitabine—stomach cancer	0.000138	0.00041	CcSEcCtD
Aprepitant—Angiopathy—Doxorubicin—stomach cancer	0.000138	0.00041	CcSEcCtD
Aprepitant—Malaise—Methotrexate—stomach cancer	0.000138	0.000409	CcSEcCtD
Aprepitant—Muscle spasms—Epirubicin—stomach cancer	0.000138	0.000408	CcSEcCtD
Aprepitant—Immune system disorder—Doxorubicin—stomach cancer	0.000137	0.000408	CcSEcCtD
Aprepitant—Gastrointestinal pain—Capecitabine—stomach cancer	0.000137	0.000407	CcSEcCtD
Aprepitant—Mediastinal disorder—Doxorubicin—stomach cancer	0.000137	0.000407	CcSEcCtD
Aprepitant—Abdominal pain—Docetaxel—stomach cancer	0.000137	0.000406	CcSEcCtD
Aprepitant—Body temperature increased—Docetaxel—stomach cancer	0.000137	0.000406	CcSEcCtD
Aprepitant—Chills—Doxorubicin—stomach cancer	0.000136	0.000405	CcSEcCtD
Aprepitant—Alopecia—Doxorubicin—stomach cancer	0.000134	0.000399	CcSEcCtD
Aprepitant—Cough—Methotrexate—stomach cancer	0.000133	0.000396	CcSEcCtD
Aprepitant—Mental disorder—Doxorubicin—stomach cancer	0.000133	0.000396	CcSEcCtD
Aprepitant—Urticaria—Capecitabine—stomach cancer	0.000133	0.000395	CcSEcCtD
Aprepitant—Ill-defined disorder—Epirubicin—stomach cancer	0.000133	0.000394	CcSEcCtD
Aprepitant—Abdominal pain—Capecitabine—stomach cancer	0.000132	0.000393	CcSEcCtD
Aprepitant—Body temperature increased—Capecitabine—stomach cancer	0.000132	0.000393	CcSEcCtD
Aprepitant—Convulsion—Methotrexate—stomach cancer	0.000132	0.000393	CcSEcCtD
Aprepitant—Erythema—Doxorubicin—stomach cancer	0.000132	0.000393	CcSEcCtD
Aprepitant—Malnutrition—Doxorubicin—stomach cancer	0.000132	0.000393	CcSEcCtD
Aprepitant—Anaemia—Epirubicin—stomach cancer	0.000132	0.000393	CcSEcCtD
Aprepitant—Flatulence—Doxorubicin—stomach cancer	0.00013	0.000387	CcSEcCtD
Aprepitant—Myalgia—Methotrexate—stomach cancer	0.00013	0.000387	CcSEcCtD
Aprepitant—Chest pain—Methotrexate—stomach cancer	0.00013	0.000387	CcSEcCtD
Aprepitant—Arthralgia—Methotrexate—stomach cancer	0.00013	0.000387	CcSEcCtD
Aprepitant—Dysgeusia—Doxorubicin—stomach cancer	0.00013	0.000385	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000129	0.000384	CcSEcCtD
Aprepitant—Malaise—Epirubicin—stomach cancer	0.000129	0.000383	CcSEcCtD
Aprepitant—Discomfort—Methotrexate—stomach cancer	0.000129	0.000382	CcSEcCtD
Aprepitant—Syncope—Epirubicin—stomach cancer	0.000128	0.000381	CcSEcCtD
Aprepitant—Back pain—Doxorubicin—stomach cancer	0.000128	0.00038	CcSEcCtD
Aprepitant—Hypersensitivity—Docetaxel—stomach cancer	0.000128	0.000379	CcSEcCtD
Aprepitant—Muscle spasms—Doxorubicin—stomach cancer	0.000127	0.000378	CcSEcCtD
Aprepitant—Palpitations—Epirubicin—stomach cancer	0.000126	0.000375	CcSEcCtD
Aprepitant—Confusional state—Methotrexate—stomach cancer	0.000126	0.000374	CcSEcCtD
Aprepitant—Loss of consciousness—Epirubicin—stomach cancer	0.000126	0.000373	CcSEcCtD
Aprepitant—Cough—Epirubicin—stomach cancer	0.000125	0.000371	CcSEcCtD
Aprepitant—Anaphylactic shock—Methotrexate—stomach cancer	0.000125	0.000371	CcSEcCtD
Aprepitant—Asthenia—Docetaxel—stomach cancer	0.000124	0.000369	CcSEcCtD
Aprepitant—Convulsion—Epirubicin—stomach cancer	0.000124	0.000368	CcSEcCtD
Aprepitant—Infection—Methotrexate—stomach cancer	0.000124	0.000368	CcSEcCtD
Aprepitant—Hypertension—Epirubicin—stomach cancer	0.000123	0.000367	CcSEcCtD
Aprepitant—Hypersensitivity—Capecitabine—stomach cancer	0.000123	0.000367	CcSEcCtD
Aprepitant—Ill-defined disorder—Doxorubicin—stomach cancer	0.000123	0.000365	CcSEcCtD
Aprepitant—Pruritus—Docetaxel—stomach cancer	0.000122	0.000364	CcSEcCtD
Aprepitant—Nervous system disorder—Methotrexate—stomach cancer	0.000122	0.000363	CcSEcCtD
Aprepitant—Anaemia—Doxorubicin—stomach cancer	0.000122	0.000363	CcSEcCtD
Aprepitant—Thrombocytopenia—Methotrexate—stomach cancer	0.000122	0.000363	CcSEcCtD
Aprepitant—Myalgia—Epirubicin—stomach cancer	0.000122	0.000362	CcSEcCtD
Aprepitant—Arthralgia—Epirubicin—stomach cancer	0.000122	0.000362	CcSEcCtD
Aprepitant—Chest pain—Epirubicin—stomach cancer	0.000122	0.000362	CcSEcCtD
Aprepitant—Anxiety—Epirubicin—stomach cancer	0.000121	0.00036	CcSEcCtD
Aprepitant—Skin disorder—Methotrexate—stomach cancer	0.000121	0.00036	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000121	0.000359	CcSEcCtD
Aprepitant—Hyperhidrosis—Methotrexate—stomach cancer	0.000121	0.000358	CcSEcCtD
Aprepitant—Discomfort—Epirubicin—stomach cancer	0.00012	0.000357	CcSEcCtD
Aprepitant—Asthenia—Capecitabine—stomach cancer	0.00012	0.000357	CcSEcCtD
Aprepitant—Malaise—Doxorubicin—stomach cancer	0.000119	0.000354	CcSEcCtD
Aprepitant—Dry mouth—Epirubicin—stomach cancer	0.000119	0.000354	CcSEcCtD
Aprepitant—Anorexia—Methotrexate—stomach cancer	0.000119	0.000353	CcSEcCtD
Aprepitant—Syncope—Doxorubicin—stomach cancer	0.000119	0.000353	CcSEcCtD
Aprepitant—Pruritus—Capecitabine—stomach cancer	0.000119	0.000352	CcSEcCtD
Aprepitant—Diarrhoea—Docetaxel—stomach cancer	0.000118	0.000352	CcSEcCtD
Aprepitant—Confusional state—Epirubicin—stomach cancer	0.000118	0.00035	CcSEcCtD
Aprepitant—Palpitations—Doxorubicin—stomach cancer	0.000117	0.000347	CcSEcCtD
Aprepitant—Anaphylactic shock—Epirubicin—stomach cancer	0.000117	0.000347	CcSEcCtD
Aprepitant—Oedema—Epirubicin—stomach cancer	0.000117	0.000347	CcSEcCtD
Aprepitant—Hypotension—Methotrexate—stomach cancer	0.000117	0.000346	CcSEcCtD
Aprepitant—Loss of consciousness—Doxorubicin—stomach cancer	0.000116	0.000346	CcSEcCtD
Aprepitant—Infection—Epirubicin—stomach cancer	0.000116	0.000344	CcSEcCtD
Aprepitant—Cough—Doxorubicin—stomach cancer	0.000115	0.000343	CcSEcCtD
Aprepitant—Shock—Epirubicin—stomach cancer	0.000115	0.000341	CcSEcCtD
Aprepitant—Convulsion—Doxorubicin—stomach cancer	0.000115	0.000341	CcSEcCtD
Aprepitant—Diarrhoea—Capecitabine—stomach cancer	0.000115	0.000341	CcSEcCtD
Aprepitant—Nervous system disorder—Epirubicin—stomach cancer	0.000114	0.00034	CcSEcCtD
Aprepitant—Dizziness—Docetaxel—stomach cancer	0.000114	0.00034	CcSEcCtD
Aprepitant—Thrombocytopenia—Epirubicin—stomach cancer	0.000114	0.000339	CcSEcCtD
Aprepitant—Hypertension—Doxorubicin—stomach cancer	0.000114	0.000339	CcSEcCtD
Aprepitant—Tachycardia—Epirubicin—stomach cancer	0.000114	0.000338	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000114	0.000338	CcSEcCtD
Aprepitant—Skin disorder—Epirubicin—stomach cancer	0.000113	0.000337	CcSEcCtD
Aprepitant—Hyperhidrosis—Epirubicin—stomach cancer	0.000113	0.000335	CcSEcCtD
Aprepitant—Insomnia—Methotrexate—stomach cancer	0.000113	0.000335	CcSEcCtD
Aprepitant—Arthralgia—Doxorubicin—stomach cancer	0.000113	0.000335	CcSEcCtD
Aprepitant—Myalgia—Doxorubicin—stomach cancer	0.000113	0.000335	CcSEcCtD
Aprepitant—Chest pain—Doxorubicin—stomach cancer	0.000113	0.000335	CcSEcCtD
Aprepitant—Anxiety—Doxorubicin—stomach cancer	0.000112	0.000334	CcSEcCtD
Aprepitant—Paraesthesia—Methotrexate—stomach cancer	0.000112	0.000333	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000112	0.000332	CcSEcCtD
Aprepitant—Discomfort—Doxorubicin—stomach cancer	0.000111	0.000331	CcSEcCtD
Aprepitant—Anorexia—Epirubicin—stomach cancer	0.000111	0.000331	CcSEcCtD
Aprepitant—Dyspnoea—Methotrexate—stomach cancer	0.000111	0.00033	CcSEcCtD
Aprepitant—Somnolence—Methotrexate—stomach cancer	0.000111	0.000329	CcSEcCtD
Aprepitant—Dizziness—Capecitabine—stomach cancer	0.000111	0.000329	CcSEcCtD
Aprepitant—Dry mouth—Doxorubicin—stomach cancer	0.00011	0.000327	CcSEcCtD
Aprepitant—Vomiting—Docetaxel—stomach cancer	0.00011	0.000327	CcSEcCtD
Aprepitant—Dyspepsia—Methotrexate—stomach cancer	0.00011	0.000326	CcSEcCtD
Aprepitant—Rash—Docetaxel—stomach cancer	0.000109	0.000324	CcSEcCtD
Aprepitant—Hypotension—Epirubicin—stomach cancer	0.000109	0.000324	CcSEcCtD
Aprepitant—Dermatitis—Docetaxel—stomach cancer	0.000109	0.000324	CcSEcCtD
Aprepitant—Confusional state—Doxorubicin—stomach cancer	0.000109	0.000323	CcSEcCtD
Aprepitant—Decreased appetite—Methotrexate—stomach cancer	0.000108	0.000322	CcSEcCtD
Aprepitant—Headache—Docetaxel—stomach cancer	0.000108	0.000322	CcSEcCtD
Aprepitant—Oedema—Doxorubicin—stomach cancer	0.000108	0.000321	CcSEcCtD
Aprepitant—Anaphylactic shock—Doxorubicin—stomach cancer	0.000108	0.000321	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000108	0.00032	CcSEcCtD
Aprepitant—Fatigue—Methotrexate—stomach cancer	0.000108	0.000319	CcSEcCtD
Aprepitant—Infection—Doxorubicin—stomach cancer	0.000107	0.000319	CcSEcCtD
Aprepitant—Pain—Methotrexate—stomach cancer	0.000107	0.000317	CcSEcCtD
Aprepitant—Vomiting—Capecitabine—stomach cancer	0.000107	0.000316	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000106	0.000316	CcSEcCtD
Aprepitant—Shock—Doxorubicin—stomach cancer	0.000106	0.000316	CcSEcCtD
Aprepitant—Nervous system disorder—Doxorubicin—stomach cancer	0.000106	0.000315	CcSEcCtD
Aprepitant—Thrombocytopenia—Doxorubicin—stomach cancer	0.000106	0.000314	CcSEcCtD
Aprepitant—Rash—Capecitabine—stomach cancer	0.000106	0.000314	CcSEcCtD
Aprepitant—Insomnia—Epirubicin—stomach cancer	0.000106	0.000314	CcSEcCtD
Aprepitant—Dermatitis—Capecitabine—stomach cancer	0.000106	0.000314	CcSEcCtD
Aprepitant—Tachycardia—Doxorubicin—stomach cancer	0.000105	0.000313	CcSEcCtD
Aprepitant—Headache—Capecitabine—stomach cancer	0.000105	0.000312	CcSEcCtD
Aprepitant—Skin disorder—Doxorubicin—stomach cancer	0.000105	0.000312	CcSEcCtD
Aprepitant—Paraesthesia—Epirubicin—stomach cancer	0.000105	0.000311	CcSEcCtD
Aprepitant—Hyperhidrosis—Doxorubicin—stomach cancer	0.000104	0.00031	CcSEcCtD
Aprepitant—Dyspnoea—Epirubicin—stomach cancer	0.000104	0.000309	CcSEcCtD
Aprepitant—Somnolence—Epirubicin—stomach cancer	0.000104	0.000308	CcSEcCtD
Aprepitant—Anorexia—Doxorubicin—stomach cancer	0.000103	0.000306	CcSEcCtD
Aprepitant—Nausea—Docetaxel—stomach cancer	0.000103	0.000305	CcSEcCtD
Aprepitant—Feeling abnormal—Methotrexate—stomach cancer	0.000103	0.000305	CcSEcCtD
Aprepitant—Dyspepsia—Epirubicin—stomach cancer	0.000103	0.000305	CcSEcCtD
Aprepitant—Gastrointestinal pain—Methotrexate—stomach cancer	0.000102	0.000303	CcSEcCtD
Aprepitant—Decreased appetite—Epirubicin—stomach cancer	0.000101	0.000301	CcSEcCtD
Aprepitant—Hypotension—Doxorubicin—stomach cancer	0.000101	0.0003	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000101	0.000299	CcSEcCtD
Aprepitant—Fatigue—Epirubicin—stomach cancer	0.000101	0.000299	CcSEcCtD
Aprepitant—Constipation—Epirubicin—stomach cancer	9.98e-05	0.000297	CcSEcCtD
Aprepitant—Pain—Epirubicin—stomach cancer	9.98e-05	0.000297	CcSEcCtD
Aprepitant—Nausea—Capecitabine—stomach cancer	9.95e-05	0.000296	CcSEcCtD
Aprepitant—Urticaria—Methotrexate—stomach cancer	9.91e-05	0.000294	CcSEcCtD
Aprepitant—Abdominal pain—Methotrexate—stomach cancer	9.86e-05	0.000293	CcSEcCtD
Aprepitant—Body temperature increased—Methotrexate—stomach cancer	9.86e-05	0.000293	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Doxorubicin—stomach cancer	9.84e-05	0.000292	CcSEcCtD
Aprepitant—Insomnia—Doxorubicin—stomach cancer	9.77e-05	0.00029	CcSEcCtD
Aprepitant—Paraesthesia—Doxorubicin—stomach cancer	9.7e-05	0.000288	CcSEcCtD
Aprepitant—Dyspnoea—Doxorubicin—stomach cancer	9.63e-05	0.000286	CcSEcCtD
Aprepitant—Feeling abnormal—Epirubicin—stomach cancer	9.62e-05	0.000286	CcSEcCtD
Aprepitant—Somnolence—Doxorubicin—stomach cancer	9.6e-05	0.000285	CcSEcCtD
Aprepitant—Gastrointestinal pain—Epirubicin—stomach cancer	9.55e-05	0.000284	CcSEcCtD
Aprepitant—Dyspepsia—Doxorubicin—stomach cancer	9.51e-05	0.000282	CcSEcCtD
Aprepitant—Decreased appetite—Doxorubicin—stomach cancer	9.39e-05	0.000279	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Doxorubicin—stomach cancer	9.32e-05	0.000277	CcSEcCtD
Aprepitant—Fatigue—Doxorubicin—stomach cancer	9.31e-05	0.000277	CcSEcCtD
Aprepitant—Urticaria—Epirubicin—stomach cancer	9.27e-05	0.000275	CcSEcCtD
Aprepitant—Pain—Doxorubicin—stomach cancer	9.24e-05	0.000274	CcSEcCtD
Aprepitant—Constipation—Doxorubicin—stomach cancer	9.24e-05	0.000274	CcSEcCtD
Aprepitant—Abdominal pain—Epirubicin—stomach cancer	9.23e-05	0.000274	CcSEcCtD
Aprepitant—Body temperature increased—Epirubicin—stomach cancer	9.23e-05	0.000274	CcSEcCtD
Aprepitant—Hypersensitivity—Methotrexate—stomach cancer	9.19e-05	0.000273	CcSEcCtD
Aprepitant—Asthenia—Methotrexate—stomach cancer	8.95e-05	0.000266	CcSEcCtD
Aprepitant—Feeling abnormal—Doxorubicin—stomach cancer	8.9e-05	0.000264	CcSEcCtD
Aprepitant—Gastrointestinal pain—Doxorubicin—stomach cancer	8.83e-05	0.000262	CcSEcCtD
Aprepitant—Pruritus—Methotrexate—stomach cancer	8.83e-05	0.000262	CcSEcCtD
Aprepitant—Hypersensitivity—Epirubicin—stomach cancer	8.6e-05	0.000255	CcSEcCtD
Aprepitant—Urticaria—Doxorubicin—stomach cancer	8.58e-05	0.000255	CcSEcCtD
Aprepitant—Abdominal pain—Doxorubicin—stomach cancer	8.54e-05	0.000254	CcSEcCtD
Aprepitant—Body temperature increased—Doxorubicin—stomach cancer	8.54e-05	0.000254	CcSEcCtD
Aprepitant—Diarrhoea—Methotrexate—stomach cancer	8.53e-05	0.000254	CcSEcCtD
Aprepitant—Asthenia—Epirubicin—stomach cancer	8.38e-05	0.000249	CcSEcCtD
Aprepitant—Pruritus—Epirubicin—stomach cancer	8.26e-05	0.000245	CcSEcCtD
Aprepitant—Dizziness—Methotrexate—stomach cancer	8.25e-05	0.000245	CcSEcCtD
Aprepitant—Diarrhoea—Epirubicin—stomach cancer	7.99e-05	0.000237	CcSEcCtD
Aprepitant—Hypersensitivity—Doxorubicin—stomach cancer	7.96e-05	0.000236	CcSEcCtD
Aprepitant—Vomiting—Methotrexate—stomach cancer	7.93e-05	0.000236	CcSEcCtD
Aprepitant—Rash—Methotrexate—stomach cancer	7.86e-05	0.000234	CcSEcCtD
Aprepitant—Dermatitis—Methotrexate—stomach cancer	7.86e-05	0.000233	CcSEcCtD
Aprepitant—Headache—Methotrexate—stomach cancer	7.81e-05	0.000232	CcSEcCtD
Aprepitant—Asthenia—Doxorubicin—stomach cancer	7.75e-05	0.00023	CcSEcCtD
Aprepitant—Dizziness—Epirubicin—stomach cancer	7.72e-05	0.000229	CcSEcCtD
Aprepitant—Pruritus—Doxorubicin—stomach cancer	7.64e-05	0.000227	CcSEcCtD
Aprepitant—Vomiting—Epirubicin—stomach cancer	7.42e-05	0.00022	CcSEcCtD
Aprepitant—Nausea—Methotrexate—stomach cancer	7.41e-05	0.00022	CcSEcCtD
Aprepitant—Diarrhoea—Doxorubicin—stomach cancer	7.39e-05	0.00022	CcSEcCtD
Aprepitant—Rash—Epirubicin—stomach cancer	7.36e-05	0.000219	CcSEcCtD
Aprepitant—Dermatitis—Epirubicin—stomach cancer	7.35e-05	0.000218	CcSEcCtD
Aprepitant—Headache—Epirubicin—stomach cancer	7.31e-05	0.000217	CcSEcCtD
Aprepitant—Dizziness—Doxorubicin—stomach cancer	7.14e-05	0.000212	CcSEcCtD
Aprepitant—Nausea—Epirubicin—stomach cancer	6.93e-05	0.000206	CcSEcCtD
Aprepitant—Vomiting—Doxorubicin—stomach cancer	6.87e-05	0.000204	CcSEcCtD
Aprepitant—Rash—Doxorubicin—stomach cancer	6.81e-05	0.000202	CcSEcCtD
Aprepitant—Dermatitis—Doxorubicin—stomach cancer	6.8e-05	0.000202	CcSEcCtD
Aprepitant—Headache—Doxorubicin—stomach cancer	6.77e-05	0.000201	CcSEcCtD
Aprepitant—Nausea—Doxorubicin—stomach cancer	6.42e-05	0.000191	CcSEcCtD
Aprepitant—CYP2C9—Metabolism—FBP1—stomach cancer	2.87e-05	0.00023	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CKB—stomach cancer	2.87e-05	0.00023	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TP53—stomach cancer	2.86e-05	0.00023	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—MAPK1—stomach cancer	2.82e-05	0.000227	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—EGFR—stomach cancer	2.82e-05	0.000227	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GSTT1—stomach cancer	2.81e-05	0.000226	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NT5E—stomach cancer	2.8e-05	0.000225	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PGAM1—stomach cancer	2.8e-05	0.000225	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP2A6—stomach cancer	2.78e-05	0.000223	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPAP2A—stomach cancer	2.75e-05	0.000221	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—HRAS—stomach cancer	2.74e-05	0.00022	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—SREBF2—stomach cancer	2.71e-05	0.000218	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AKR1C3—stomach cancer	2.7e-05	0.000217	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—PIK3CA—stomach cancer	2.7e-05	0.000217	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PLIN2—stomach cancer	2.69e-05	0.000217	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SERPINE1—stomach cancer	2.69e-05	0.000216	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—IDH3B—stomach cancer	2.68e-05	0.000216	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SUCLG1—stomach cancer	2.68e-05	0.000216	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—RORA—stomach cancer	2.68e-05	0.000215	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PLCE1—stomach cancer	2.67e-05	0.000215	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALDH7A1—stomach cancer	2.67e-05	0.000215	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—KRAS—stomach cancer	2.66e-05	0.000214	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	2.64e-05	0.000212	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ENO1—stomach cancer	2.63e-05	0.000212	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL6—stomach cancer	2.62e-05	0.000211	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CA2—stomach cancer	2.62e-05	0.000211	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—RHOA—stomach cancer	2.6e-05	0.000209	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NOS3—stomach cancer	2.57e-05	0.000207	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—UMPS—stomach cancer	2.56e-05	0.000206	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NT5E—stomach cancer	2.55e-05	0.000205	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PGAM1—stomach cancer	2.55e-05	0.000205	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ALDOB—stomach cancer	2.51e-05	0.000202	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NDUFV1—stomach cancer	2.49e-05	0.0002	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NDUFS1—stomach cancer	2.49e-05	0.0002	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—FBP1—stomach cancer	2.45e-05	0.000197	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CA1—stomach cancer	2.45e-05	0.000197	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CKB—stomach cancer	2.45e-05	0.000197	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NDUFA2—stomach cancer	2.45e-05	0.000197	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—PIK3CA—stomach cancer	2.45e-05	0.000197	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALDH7A1—stomach cancer	2.44e-05	0.000196	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PLCE1—stomach cancer	2.44e-05	0.000196	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—ERBB2—stomach cancer	2.4e-05	0.000193	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PDHA1—stomach cancer	2.38e-05	0.000191	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ECHS1—stomach cancer	2.38e-05	0.000191	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—UMPS—stomach cancer	2.34e-05	0.000188	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CD44—stomach cancer	2.34e-05	0.000188	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ALOX5—stomach cancer	2.33e-05	0.000188	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PLIN2—stomach cancer	2.3e-05	0.000185	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—DPYD—stomach cancer	2.3e-05	0.000185	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CXCL8—stomach cancer	2.28e-05	0.000183	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—HRAS—stomach cancer	2.26e-05	0.000182	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CA2—stomach cancer	2.24e-05	0.00018	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—TYMP—stomach cancer	2.24e-05	0.00018	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—FADS1—stomach cancer	2.24e-05	0.00018	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CDKN1B—stomach cancer	2.23e-05	0.000179	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PGLS—stomach cancer	2.22e-05	0.000179	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—BLVRB—stomach cancer	2.22e-05	0.000179	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PGAM1—stomach cancer	2.18e-05	0.000175	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NT5E—stomach cancer	2.18e-05	0.000175	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PDHA1—stomach cancer	2.17e-05	0.000175	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ECHS1—stomach cancer	2.17e-05	0.000175	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL6—stomach cancer	2.17e-05	0.000174	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCND1—stomach cancer	2.12e-05	0.000171	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPAP2A—stomach cancer	2.12e-05	0.00017	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—JUN—stomach cancer	2.12e-05	0.00017	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SREBF2—stomach cancer	2.1e-05	0.000169	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALDH7A1—stomach cancer	2.08e-05	0.000167	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PLCE1—stomach cancer	2.08e-05	0.000167	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—RORA—stomach cancer	2.07e-05	0.000167	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MMP9—stomach cancer	2.06e-05	0.000166	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CDKN1A—stomach cancer	2.05e-05	0.000165	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—TYMP—stomach cancer	2.04e-05	0.000164	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—FADS1—stomach cancer	2.04e-05	0.000164	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTT1—stomach cancer	2.03e-05	0.000163	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP2A6—stomach cancer	2.01e-05	0.000161	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MAPK8—stomach cancer	2e-05	0.000161	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—UMPS—stomach cancer	2e-05	0.00016	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PPP2R1A—stomach cancer	1.99e-05	0.00016	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AKR1C3—stomach cancer	1.95e-05	0.000157	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GSTP1—stomach cancer	1.95e-05	0.000157	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALDOB—stomach cancer	1.94e-05	0.000156	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—HMOX1—stomach cancer	1.92e-05	0.000154	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SREBF2—stomach cancer	1.91e-05	0.000154	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ENO1—stomach cancer	1.9e-05	0.000153	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CKB—stomach cancer	1.89e-05	0.000152	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CA1—stomach cancer	1.89e-05	0.000152	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.89e-05	0.000152	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—FBP1—stomach cancer	1.89e-05	0.000152	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—RORA—stomach cancer	1.89e-05	0.000152	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PDHA1—stomach cancer	1.86e-05	0.000149	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ECHS1—stomach cancer	1.86e-05	0.000149	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—VEGFA—stomach cancer	1.85e-05	0.000149	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—STAT3—stomach cancer	1.83e-05	0.000147	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.83e-05	0.000147	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.83e-05	0.000147	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—TYMS—stomach cancer	1.81e-05	0.000146	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALOX5—stomach cancer	1.81e-05	0.000145	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GSTM1—stomach cancer	1.79e-05	0.000144	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PLIN2—stomach cancer	1.78e-05	0.000143	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—DPYD—stomach cancer	1.78e-05	0.000143	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALDOB—stomach cancer	1.77e-05	0.000142	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MAPK3—stomach cancer	1.75e-05	0.000141	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—FADS1—stomach cancer	1.74e-05	0.00014	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—TYMP—stomach cancer	1.74e-05	0.00014	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CA2—stomach cancer	1.73e-05	0.000139	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MYC—stomach cancer	1.7e-05	0.000137	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CD44—stomach cancer	1.69e-05	0.000136	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NT5E—stomach cancer	1.68e-05	0.000135	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PGAM1—stomach cancer	1.68e-05	0.000135	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ERCC2—stomach cancer	1.68e-05	0.000135	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.67e-05	0.000134	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MAPK1—stomach cancer	1.67e-05	0.000134	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—EGFR—stomach cancer	1.67e-05	0.000134	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.67e-05	0.000134	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALOX5—stomach cancer	1.65e-05	0.000132	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SREBF2—stomach cancer	1.63e-05	0.000131	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—DPYD—stomach cancer	1.62e-05	0.00013	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—RORA—stomach cancer	1.61e-05	0.00013	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.61e-05	0.000129	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.61e-05	0.000129	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PLCE1—stomach cancer	1.61e-05	0.000129	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—MTHFR—stomach cancer	1.58e-05	0.000127	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—KRAS—stomach cancer	1.57e-05	0.000127	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTT1—stomach cancer	1.57e-05	0.000126	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP2A6—stomach cancer	1.55e-05	0.000125	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—UMPS—stomach cancer	1.54e-05	0.000124	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALDOB—stomach cancer	1.51e-05	0.000122	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AKR1C3—stomach cancer	1.51e-05	0.000121	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ENO1—stomach cancer	1.47e-05	0.000118	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.47e-05	0.000118	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CAV1—stomach cancer	1.46e-05	0.000117	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—APOA1—stomach cancer	1.46e-05	0.000117	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.45e-05	0.000116	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PIK3CA—stomach cancer	1.45e-05	0.000116	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPP2R1A—stomach cancer	1.44e-05	0.000115	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PDHA1—stomach cancer	1.43e-05	0.000115	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ECHS1—stomach cancer	1.43e-05	0.000115	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTT1—stomach cancer	1.43e-05	0.000115	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.43e-05	0.000115	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.42e-05	0.000114	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP2A6—stomach cancer	1.42e-05	0.000114	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTP1—stomach cancer	1.41e-05	0.000113	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALOX5—stomach cancer	1.41e-05	0.000113	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TP53—stomach cancer	1.4e-05	0.000112	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—HMOX1—stomach cancer	1.39e-05	0.000112	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—DPYD—stomach cancer	1.38e-05	0.000111	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AKR1C3—stomach cancer	1.38e-05	0.000111	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—TYMP—stomach cancer	1.35e-05	0.000108	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—FADS1—stomach cancer	1.35e-05	0.000108	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ENO1—stomach cancer	1.34e-05	0.000108	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—HRAS—stomach cancer	1.34e-05	0.000108	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.32e-05	0.000106	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—TYMS—stomach cancer	1.31e-05	0.000105	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CD44—stomach cancer	1.3e-05	0.000105	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTM1—stomach cancer	1.29e-05	0.000104	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PPARG—stomach cancer	1.28e-05	0.000103	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL6—stomach cancer	1.28e-05	0.000103	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.27e-05	0.000102	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SREBF2—stomach cancer	1.26e-05	0.000101	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.25e-05	0.000101	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—RORA—stomach cancer	1.25e-05	0.0001	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTT1—stomach cancer	1.22e-05	9.84e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ERCC2—stomach cancer	1.22e-05	9.78e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP2A6—stomach cancer	1.21e-05	9.72e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CD44—stomach cancer	1.19e-05	9.57e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AKR1C3—stomach cancer	1.18e-05	9.46e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALDOB—stomach cancer	1.17e-05	9.39e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.15e-05	9.28e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ALB—stomach cancer	1.15e-05	9.27e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ENO1—stomach cancer	1.15e-05	9.22e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—MTHFR—stomach cancer	1.14e-05	9.19e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.13e-05	9.07e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPP2R1A—stomach cancer	1.11e-05	8.92e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—NOS3—stomach cancer	1.1e-05	8.87e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTP1—stomach cancer	1.09e-05	8.75e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALOX5—stomach cancer	1.09e-05	8.73e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—HMOX1—stomach cancer	1.07e-05	8.63e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—DPYD—stomach cancer	1.07e-05	8.59e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CAV1—stomach cancer	1.05e-05	8.48e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—APOA1—stomach cancer	1.05e-05	8.46e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CD44—stomach cancer	1.02e-05	8.17e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—TYMS—stomach cancer	1.01e-05	8.14e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPP2R1A—stomach cancer	1.01e-05	8.13e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGS2—stomach cancer	1.01e-05	8.11e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTM1—stomach cancer	1e-05	8.04e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTP1—stomach cancer	9.92e-06	7.98e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	9.87e-06	7.93e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HMOX1—stomach cancer	9.79e-06	7.87e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTT1—stomach cancer	9.44e-06	7.59e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ERCC2—stomach cancer	9.4e-06	7.56e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP2A6—stomach cancer	9.33e-06	7.5e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPARG—stomach cancer	9.27e-06	7.45e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—TYMS—stomach cancer	9.23e-06	7.42e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTM1—stomach cancer	9.12e-06	7.33e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AKR1C3—stomach cancer	9.08e-06	7.3e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ENO1—stomach cancer	8.85e-06	7.11e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—MTHFR—stomach cancer	8.84e-06	7.11e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPP2R1A—stomach cancer	8.65e-06	6.95e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ERCC2—stomach cancer	8.57e-06	6.89e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTP1—stomach cancer	8.48e-06	6.82e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HMOX1—stomach cancer	8.36e-06	6.72e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ALB—stomach cancer	8.34e-06	6.7e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CAV1—stomach cancer	8.15e-06	6.56e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—APOA1—stomach cancer	8.14e-06	6.54e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—MTHFR—stomach cancer	8.06e-06	6.48e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—NOS3—stomach cancer	7.97e-06	6.41e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—TYMS—stomach cancer	7.88e-06	6.34e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CD44—stomach cancer	7.85e-06	6.31e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTM1—stomach cancer	7.79e-06	6.27e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7.79e-06	6.26e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CAV1—stomach cancer	7.43e-06	5.98e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—APOA1—stomach cancer	7.42e-06	5.96e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ERCC2—stomach cancer	7.33e-06	5.89e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGS2—stomach cancer	7.29e-06	5.86e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPARG—stomach cancer	7.17e-06	5.76e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7.1e-06	5.71e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MTHFR—stomach cancer	6.89e-06	5.54e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPP2R1A—stomach cancer	6.67e-06	5.36e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTP1—stomach cancer	6.55e-06	5.26e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPARG—stomach cancer	6.54e-06	5.25e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HMOX1—stomach cancer	6.46e-06	5.19e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALB—stomach cancer	6.45e-06	5.18e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CAV1—stomach cancer	6.35e-06	5.11e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOA1—stomach cancer	6.34e-06	5.1e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CA—stomach cancer	6.21e-06	4.99e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NOS3—stomach cancer	6.17e-06	4.96e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—TYMS—stomach cancer	6.08e-06	4.89e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.07e-06	4.88e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTM1—stomach cancer	6.01e-06	4.84e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALB—stomach cancer	5.88e-06	4.72e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ERCC2—stomach cancer	5.66e-06	4.55e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS2—stomach cancer	5.64e-06	4.53e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NOS3—stomach cancer	5.62e-06	4.52e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPARG—stomach cancer	5.59e-06	4.49e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MTHFR—stomach cancer	5.32e-06	4.27e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS2—stomach cancer	5.14e-06	4.13e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALB—stomach cancer	5.02e-06	4.04e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CAV1—stomach cancer	4.9e-06	3.94e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOA1—stomach cancer	4.89e-06	3.93e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NOS3—stomach cancer	4.8e-06	3.86e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CA—stomach cancer	4.49e-06	3.61e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS2—stomach cancer	4.39e-06	3.53e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPARG—stomach cancer	4.31e-06	3.47e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALB—stomach cancer	3.88e-06	3.12e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NOS3—stomach cancer	3.71e-06	2.98e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CA—stomach cancer	3.47e-06	2.79e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS2—stomach cancer	3.39e-06	2.73e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CA—stomach cancer	3.16e-06	2.54e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CA—stomach cancer	2.7e-06	2.17e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CA—stomach cancer	2.09e-06	1.68e-05	CbGpPWpGaD
